Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-000758
Filing Date
2025-01-06
Accepted
2025-01-06 16:22:15
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2947
  Complete submission text file 0001127602-25-000758.txt   4479
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Issuer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12790 EL CAMINO REAL C/O NEUROCRINE BIOSCIENCES SAN DIEGO CA 92130
Business Address
WIERENGA WENDALL (Reporting) CIK: 0001235945 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50633 | Film No.: 25511448